Recent Posts
- Parkinson’s puts our ‘in sickness and in health’ vows to the test
- Parkinson’s gene therapy reduced alpha-synuclein in animal models
- Drug blocks toxic alpha-synuclein clumps in human brain tissue in lab
- Parkinson’s therapy is tolerated well, clearing path for Phase 2 trial
- Parkinson’s therapy ARV-102 able to reach brain, where needed: Study